SALT LAKE CITY--(BUSINESS WIRE)--Epitel, a leader in AI for patient-focused brain health technologies, announced today it received U.S. Food and Drug Administration (FDA) 510(k) clearance for REMI ...
Younger children and infants at least one year of age benefit from a wireless system that integrates brain health monitoring into a child’s regular routine with drastically less disruption than ...
The US Food and Drug Administration (FDA) has granted expanded 510(k) clearance for Epitel’s REMI Wireless electroencephalogram (EEG) System for neurological monitoring in infants and paediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results